About the journal
Atherosclerosis Plus is an open-access journal published by Elsevier in Netherlands, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,910 USD. Declared review time at DOAJ: 12 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 2667-0909 · 2667-0895
- Country
- Netherlands
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,910 USD
- Articles in DOAJ
- 248
- Declared review time
- 12 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.sciencedirect.com/journal/atherosclerosis-plus
Index listings
- DOAJ · 2021-12-07
- Indexing
- DOAJ
- APC
- 2,910 USD
- Declared review time (DOAJ)
- 12 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
248
Most recent article
last month
Average review time (journal-declared via DOAJ)
12weeks
Works in OpenAlex
288
Last recorded publication year
2026
h-index
15
i10-index
35
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2021-12-07
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 61%
- ORCID iDs in current deposits
- 49%
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9918249514806676
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Lipoproteins and Cardiovascular Health
- Lipoproteins and Cardiovascular Health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Atherosclerosis and Cardiovascular Diseases
- Atherosclerosis and Cardiovascular Diseases
- Cholesterol and Lipid Metabolism
- Diverse Scientific and Economic Studies
Show all subjects (50)
- Diverse Scientific and Economic Studies
- Cancer, Lipids, and Metabolism
- Cancer, Lipids, and Metabolism
- Lipid metabolism and disorders
- Human auditory perception and evaluation
- Educational Robotics and Engineering
- Cholesterol and Lipid Metabolism
- Lipid metabolism and disorders
- Educational Robotics and Engineering
- Human auditory perception and evaluation
- Adipokines, Inflammation, and Metabolic Diseases
- Adipokines, Inflammation, and Metabolic Diseases
- Cerebrovascular and Carotid Artery Diseases
- Cardiovascular Health and Disease Prevention
- Cerebrovascular and Carotid Artery Diseases
- Cardiovascular Health and Disease Prevention
- HIV-related health complications and treatments
- Parathyroid Disorders and Treatments
- Parathyroid Disorders and Treatments
- Cardiovascular Disease and Adiposity
- HIV-related health complications and treatments
- Genetic Associations and Epidemiology
- Peripheral Artery Disease Management
- Coronary Interventions and Diagnostics
- Protease and Inhibitor Mechanisms
- Coronary Interventions and Diagnostics
- Genetic Associations and Epidemiology
- Health Systems, Economic Evaluations, Quality of Life
- Cardiovascular Disease and Adiposity
- Diabetes Treatment and Management
- Liver Disease Diagnosis and Treatment
- Diabetes Treatment and Management
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Cardiac Imaging and Diagnostics
- Protease and Inhibitor Mechanisms
- Peripheral Artery Disease Management
- Cardiac Imaging and Diagnostics
- COVID-19 Clinical Research Studies
- Liver Disease Diagnosis and Treatment
- Inflammatory Biomarkers in Disease Prognosis
- Health Systems, Economic Evaluations, Quality of Life
- COVID-19 Clinical Research Studies
Keywords (DOAJ)
- atherosclerosis
- genetics
- cardiovascular disease
- lifestyle disease
- cardiovascular medicine
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ